Evidence map›Paper›PMID 38760420›Full record

ArticleScientific reports2024

Identification of cancer risk groups through multi-omics integration using autoencoder and tensor analysis.

Ali Braytee, Sam He, Shuxian Tang, Yuxuan Sun, Xiaoying Jiang, Xuanding Yu, Inder Khatri, Kunal Chaturvedi, Mukesh Prasad, Ali Anaissi

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Multi-Omics Integration for Advancing Glioma Precision Medicine.Annals of clinical and translational neurology · 2026
    Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ali Braytee *School of Computer Science, University of Technology Sydney, Ultimo, 2007, Australia. ali.braytee@uts.edu.au.
Sam He *School of Computer Science, The University of Sydney, Camperdown, 2006, Australia.
Shuxian TangSchool of Computer Science, The University of Sydney, Camperdown, 2006, Australia.
Yuxuan SunSchool of Computer Science, The University of Sydney, Camperdown, 2006, Australia.
Xiaoying JiangSchool of Computer Science, The University of Sydney, Camperdown, 2006, Australia.
Xuanding YuSchool of Computer Science, The University of Sydney, Camperdown, 2006, Australia.
Inder KhatriDepartment of Applied Mathematics, Delhi Technological University, Delhi, 110042, India.
Kunal ChaturvediSchool of Computer Science, University of Technology Sydney, Ultimo, 2007, Australia.
Mukesh PrasadSchool of Computer Science, University of Technology Sydney, Ultimo, 2007, Australia.
Ali AnaissiSchool of Computer Science, The University of Sydney, Camperdown, 2006, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identifying cancer risk groups by multi-omics has attracted researchers in their quest to find biomarkers from diverse risk-related omics. Stratifying the patients into cancer risk groups using genomics is essential for clinicians for pre-prevention treatment to improve the survival time for patients and identify the appropriate therapy strategies. This study proposes a multi-omics framework that can extract the features from various omics simultaneously. The framework employs autoencoders to learn the non-linear representation of the data and applies tensor analysis for feature learning. Further, the clustering method is used to stratify the patients into multiple cancer risk groups. Several omics were included in the experiments, namely methylation, somatic copy-number variation (SCNV), micro RNA (miRNA) and RNA sequencing (RNAseq) from two cancer types, including Glioma and Breast Invasive Carcinoma from the TCGA dataset. The results of this study are promising, as evidenced by the survival analysis and classification models, which outperformed the state-of-the-art. The patients can be significantly (p-value<0.05) divided into risk groups using extracted latent variables from the fused multi-omics data. The pipeline is open source to help researchers and clinicians identify the patients' risk groups using genomics.

Indexed as

DNA Copy Number VariationsGenomicsBiomarkers, TumorBreast NeoplasmsDNA MethylationFemaleGliomaHumansMicroRNAsMultiomicsNeoplasmsBiomarkers, TumorMicroRNAs

Identifiers

PMID38760420
PMCPMC11101416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.